Literature DB >> 33087436

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease.

Mark W Tenforde1,2, Timothée Boyer-Chammard3, Charles Muthoga4,5, Leabaneng Tawe4, Thandi Milton4, Ikanyeng Rulaganyang4, Kwana Lechiile4,5, Ivy Rukasha6, Tshepo B Leeme5, Nelesh P Govender6, Julia Ngidi7, Madisa Mine7, Síle F Molloy8, Thomas S Harrison8, Olivier Lortholary3,9, Joseph N Jarvis10,5,11.   

Abstract

High cryptococcal antigen (CrAg) titers in blood are associated with subclinical meningitis and mortality in CrAg-positive individuals with advanced HIV disease (AHD). We evaluated a novel semiquantitative lateral flow assay (LFA), CryptoPS, that may be able to identify individuals with high CrAg titers in a cohort of AHD patients undergoing CrAg screening. In a prospective cohort of patients with AHD (CD4 cell count, ≤200/μl) receiving CD4 count testing, whole blood was tested for CrAg by CryptoPS and the IMMY LFA; the two assays were conducted by two different operators, each blind to the results of the other assay. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CryptoPS were assessed against the IMMY LFA as a reference. CryptoPS low-titer (T1 band) and high-titer (T2 band) results were compared with IMMY LFA titers obtained through serial dilution. A total of 916 specimens were tested. The sensitivity of the CryptoPS assay was 61.0% (25/41) (95% confidence interval [95% CI], 44.5 to 75.8%), its specificity was 96.6% (845/875) (95% CI, 95.1 to 97.7%), its PPV was 45.5% (95% CI, 32.0 to 59.4%), and its NPV was 98.1% (95% CI, 97.0 to 98.9%). All (16/16) CryptoPS false-negative results were obtained for samples with IMMY titers of ≤1:160. Of 29 patients (30 specimens) who tested positive by CryptoPS but negative by the IMMY LFA, none developed cryptococcal meningitis over 3 months of follow-up without fluconazole. Median CrAg titers were 1:20 (interquartile range [IQR], 0 to 1:160) in CryptoPS T1-positive samples and 1:2,560 (IQR, 1:1,280 to 1:10,240) in T2-positive samples. We conclude that the diagnostic accuracy of the CryptoPS assay was suboptimal in the context of CrAg screening, with poor sensitivity at low CrAg titers. However, the CryptoPS assay reliably detected individuals with high titers, which are associated with poor outcomes.
Copyright © 2020 Tenforde et al.

Entities:  

Keywords:  Botswana; CrAg; HIV; cryptococcal antigen; cryptococcal meningitis; cryptococcosis; diagnostics; lateral flow assay; semiquantitative

Mesh:

Substances:

Year:  2020        PMID: 33087436      PMCID: PMC7771453          DOI: 10.1128/JCM.02307-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  3 in total

1.  Neglecting Genetic Diversity Hinders Timely Diagnosis of Cryptococcus Infections.

Authors:  Dongmei Shi; Pieter-Jan Haas; Teun Boekhout; Rosane C Hahn; Ferry Hagen
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Association of semi-quantitative cryptococcal antigen results in plasma with subclinical cryptococcal meningitis and mortality among patients with advanced HIV disease.

Authors:  Nozuko P Blasich; Rachel M Wake; Ivy Rukasha; Yvonne Prince; Nelesh P Govender
Journal:  Med Mycol       Date:  2021-10-04       Impact factor: 3.747

3.  Comparison of a Lateral Flow Assay and a Latex Agglutination Test for the Diagnosis of Cryptococcus Neoformans Infection.

Authors:  Thilo Schub; Johannes Forster; Sebastian Suerbaum; Johannes Wagener; Karl Dichtl
Journal:  Curr Microbiol       Date:  2021-09-28       Impact factor: 2.188

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.